Controversies in implementing non‐invasive prenatal testing in a public antenatal care program
Abstract Women's autonomy and an inclusive society for all individuals are highly valued in Norway. The Norwegian Biotechnology Act changed in 2020 allowing first‐trimester screening and cell‐free DNA for common trisomies to all pregnant women. However, implementing non‐invasive prenatal testin...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | Acta Obstetricia et Gynecologica Scandinavica |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/aogs.14351 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849422657790935040 |
|---|---|
| author | Kjell Åsmund Blix Salvesen Ragnhild Glad Vasilis Sitras |
| author_facet | Kjell Åsmund Blix Salvesen Ragnhild Glad Vasilis Sitras |
| author_sort | Kjell Åsmund Blix Salvesen |
| collection | DOAJ |
| description | Abstract Women's autonomy and an inclusive society for all individuals are highly valued in Norway. The Norwegian Biotechnology Act changed in 2020 allowing first‐trimester screening and cell‐free DNA for common trisomies to all pregnant women. However, implementing non‐invasive prenatal testing (NIPT) in a public antenatal care program is difficult, because many patients, politicians, and medical professionals do not consider trisomy 21 a severe medical disease. Screening for trisomies at an early gestation might inevitably lead to an increase in pregnancy terminations and making cost–benefit calculations is ethically challenging. Moreover, offering NIPT to all pregnant women is debatable because of the lower prevalence of fetal trisomies in younger women. Therefore, appropriate genetic pre‐test counseling is essential. Furthermore, organizing the service between private institutions and public hospitals poses another debate and challenges both quality and equal access to health services for women across the country. |
| format | Article |
| id | doaj-art-0ca598ca08704a1db0e49a6845e3a2b6 |
| institution | Kabale University |
| issn | 0001-6349 1600-0412 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | Acta Obstetricia et Gynecologica Scandinavica |
| spelling | doaj-art-0ca598ca08704a1db0e49a6845e3a2b62025-08-20T03:30:57ZengWileyActa Obstetricia et Gynecologica Scandinavica0001-63491600-04122022-06-01101657758010.1111/aogs.14351Controversies in implementing non‐invasive prenatal testing in a public antenatal care programKjell Åsmund Blix Salvesen0Ragnhild Glad1Vasilis Sitras2Department of Obstetrics and Gynecology St. Olavs Hospital, Trondheim University Hospital Trondheim NorwayDepartment of Medical Genetics University Hospital of North Norway Tromsø NorwayDepartment of Fetal Medicine Oslo University Hospital Oslo NorwayAbstract Women's autonomy and an inclusive society for all individuals are highly valued in Norway. The Norwegian Biotechnology Act changed in 2020 allowing first‐trimester screening and cell‐free DNA for common trisomies to all pregnant women. However, implementing non‐invasive prenatal testing (NIPT) in a public antenatal care program is difficult, because many patients, politicians, and medical professionals do not consider trisomy 21 a severe medical disease. Screening for trisomies at an early gestation might inevitably lead to an increase in pregnancy terminations and making cost–benefit calculations is ethically challenging. Moreover, offering NIPT to all pregnant women is debatable because of the lower prevalence of fetal trisomies in younger women. Therefore, appropriate genetic pre‐test counseling is essential. Furthermore, organizing the service between private institutions and public hospitals poses another debate and challenges both quality and equal access to health services for women across the country.https://doi.org/10.1111/aogs.14351cell‐free DNA screeningnon‐invasive prenatal testingNorwayprenatal screeningpublic antenatal care |
| spellingShingle | Kjell Åsmund Blix Salvesen Ragnhild Glad Vasilis Sitras Controversies in implementing non‐invasive prenatal testing in a public antenatal care program Acta Obstetricia et Gynecologica Scandinavica cell‐free DNA screening non‐invasive prenatal testing Norway prenatal screening public antenatal care |
| title | Controversies in implementing non‐invasive prenatal testing in a public antenatal care program |
| title_full | Controversies in implementing non‐invasive prenatal testing in a public antenatal care program |
| title_fullStr | Controversies in implementing non‐invasive prenatal testing in a public antenatal care program |
| title_full_unstemmed | Controversies in implementing non‐invasive prenatal testing in a public antenatal care program |
| title_short | Controversies in implementing non‐invasive prenatal testing in a public antenatal care program |
| title_sort | controversies in implementing non invasive prenatal testing in a public antenatal care program |
| topic | cell‐free DNA screening non‐invasive prenatal testing Norway prenatal screening public antenatal care |
| url | https://doi.org/10.1111/aogs.14351 |
| work_keys_str_mv | AT kjellasmundblixsalvesen controversiesinimplementingnoninvasiveprenataltestinginapublicantenatalcareprogram AT ragnhildglad controversiesinimplementingnoninvasiveprenataltestinginapublicantenatalcareprogram AT vasilissitras controversiesinimplementingnoninvasiveprenataltestinginapublicantenatalcareprogram |